Literature DB >> 19192750

Effects of modified ultrafiltration on coagulation as measured by the thromboelastograph.

Thomas G Steffens1, Takushi Kohmoto, Niloo Edwards, Richard L Wolman, David W Holt.   

Abstract

Hemodilution during cardiopulmonary bypass (CPB) continues to be a cause of morbidity associated with coagulation dysfunction, bleeding, and allogeneic blood transfusion. Clot formation and strength have been shown to impact bleeding and transfusions. Strategies to reduce hemodilution may be negated based on the course of the cardiac procedure itself. Modified ultrafiltration (MUF) is commonly used in pediatric cardiac surgery; however, it is not well accepted in adult surgery. This study aimed to evaluate clot formation and strength, bleeding, and transfusions in adult subjects undergoing MUF. Nineteen subjects having primary coronary artery bypass, aortic, or mitral valve surgeries were recruited and randomized to having MUF (n = 10) or no-MUF (n = 9) performed after the termination of CPB. Five time points for data collection were designated: T1, baseline/induction; T2, termination CPB; T3, post-MUF; T4, post-protamine; T5, 24 hours postoperative. Subjects randomized to MUF had 1505 +/- 15.8 mL of effluent removed, and no-MUF subjects had the CPB remnants processed with a cell salvage device. There was no statistical difference seen in 24-hour chest tube output, thromboelastograph values, or allogeneic transfusions at any time point between MUF and no-MUF subjects. There was a significant difference between MUF and no-MUF in the number of autologous cell salvage units processed (1.3 +/- .48 vs. 2.9 +/- .78, p = .0013) and end of procedure net fluid balance (+2003 +/- 1211 vs. +4194 +/- 1276 mL, p = .001), respectively. Estimated plasma loss from the cell salvage device was 477.6 mL greater in the no-MUF group. In primary adult cardiac procedures, MUF did not change coagulation values as measured by thromboelastography, number of allogeneic unit transfusions, or chest tube output at 24 hours postoperatively. There was a significant difference in autologous cell salvage units processed and end of procedure net fluid balance that benefited MUF subjects.

Entities:  

Mesh:

Year:  2008        PMID: 19192750      PMCID: PMC4680710     

Source DB:  PubMed          Journal:  J Extra Corpor Technol        ISSN: 0022-1058


  18 in total

1.  The effects of modified hemofiltration on inflammatory mediators and cardiac performance in coronary artery bypass grafting.

Authors:  M Bogă; I Badak; M Cikirikçioğlu; T Bakalim; T Yağdi; S Büket; A Hamulu
Journal:  Perfusion       Date:  2000-03       Impact factor: 1.972

2.  Influence of modified ultrafiltration on coagulation, fibrinolysis and blood loss in adult cardiac surgery.

Authors:  R G Leyh; C Bartels; E Joubert-Hübner; J F Bechtel; H H Sievers
Journal:  Eur J Cardiothorac Surg       Date:  2001-02       Impact factor: 4.191

3.  Aborted off-pump coronary artery bypass patients have much worse outcomes than on-pump or successful off-pump patients.

Authors:  Ruyun Jin; Loren F Hiratzka; Gary L Grunkemeier; Albert Krause; U Scott Page
Journal:  Circulation       Date:  2005-08-30       Impact factor: 29.690

Review 4.  Antifibrinolytic agents in cardiac surgery: current controversies.

Authors:  Daniel L Serna; Vinod H Thourani; John D Puskas
Journal:  Semin Thorac Cardiovasc Surg       Date:  2005

Review 5.  An evidence-based review of the practice of cardiopulmonary bypass in adults: a focus on neurologic injury, glycemic control, hemodilution, and the inflammatory response.

Authors:  Kenneth G Shann; Donald S Likosky; John M Murkin; Robert A Baker; Yvon R Baribeau; Gordon R DeFoe; Timothy A Dickinson; Timothy J Gardner; Hilary P Grocott; Gerald T O'Connor; David J Rosinski; Frank W Sellke; Timothy W Willcox
Journal:  J Thorac Cardiovasc Surg       Date:  2006-08       Impact factor: 5.209

6.  The risk associated with aprotinin in cardiac surgery.

Authors:  Dennis T Mangano; Iulia C Tudor; Cynthia Dietzel
Journal:  N Engl J Med       Date:  2006-01-26       Impact factor: 91.245

7.  A successful modification of ultrafiltration for cardiopulmonary bypass in children.

Authors:  S K Naik; A Knight; M J Elliott
Journal:  Perfusion       Date:  1991       Impact factor: 1.972

8.  Modified ultrafiltration removes serum interleukin-8 in adult cardiac surgery.

Authors:  M Onoe; T Magara; Y Yamamoto; T Nojima
Journal:  Perfusion       Date:  2001-01       Impact factor: 1.972

9.  Modified ultrafiltration reduces morbidity after adult cardiac operations: a prospective, randomized clinical trial.

Authors:  G B Luciani; T Menon; B Vecchi; S Auriemma; A Mazzucco
Journal:  Circulation       Date:  2001-09-18       Impact factor: 29.690

10.  Retrograde autologous prime with shortened bypass circuits decreases blood transfusion in high-risk coronary artery surgery patients.

Authors:  Edy S Zelinka; Patrick Ryan; Julie McDonald; James Larson
Journal:  J Extra Corpor Technol       Date:  2004-12
View more
  3 in total

Review 1.  Modified ultrafiltration during cardiopulmonary bypass and postoperative course of pediatric cardiac surgery.

Authors:  Mohsen Ziyaeifard; Azin Alizadehasl; Gholamreza Massoumi
Journal:  Res Cardiovasc Med       Date:  2014-04-01

2.  The effect of combined conventional and modified ultrafiltration on mechanical ventilation and hemodynamic changes in congenital heart surgery.

Authors:  Mohsen Ziyaeifard; Azin Alizadehasl; Nahid Aghdaii; Poupak Rahimzadeh; Gholamreza Masoumi; Samad Ej Golzari; Mostafa Fatahi; Farhad Gorjipur
Journal:  J Res Med Sci       Date:  2016-11-07       Impact factor: 1.852

3.  Modified ultrafiltration reduces postoperative blood loss and transfusions in adult cardiac surgery: a meta-analysis of randomized controlled trials.

Authors:  Zhao Kai Low; Fei Gao; Kenny Yoong Kong Sin; Kok Hooi Yap
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-05-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.